In a Controlled Human Infection Model (CHIM) study, a well-characterised strain of an infectious agent is given to carefully selected adult volunteers in order to better understand human diseases, how they spread, and find new ways to prevent and treat them. These studies play a vital role in helping to develop vaccines and treatments for infectious diseases.

A very important application of the se studies are the field of malaria clinical research. Indeed in the Controlled human malaria infection (CHMI) studies, healthy volunteers are infected with Plasmodium falciparum to assess the efficacy of novel malaria vaccines and drugs, becoming a vital tool to accelerate vaccine and drug development.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of Tuberculosis

The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone,

What if tropical diseases had as much attention as COVID?

In this article published by Nature, Prof. Francine Ntoumi addresses how the efforts to tackle Covid-19 are consequently and tragically neglecting all other diseases, for which it is estimated that

Neglected Tropical Diseases research project in Benin and Togo

R-Evolution Worldwide had the exciting opportunity to collaborate with a great team of rappresentatives from the Ministries of Health of Benin and Togo in the research project proposal: “Impact of